-
Police defenders of US Capitol sue to stop Trump 'slush fund'
-
The world built more coal power in 2025, but used less
-
'Their story is our story': Pigeons and humans, 3,500 years together
-
Musk's SpaceX is about to go public. Here's how it works
-
SpaceX, the sprawling company targeting the stars, Mars and an IPO
-
Musk eyes Wall Street record with SpaceX IPO
-
Fighting over a chicken in protest-hit La Paz
-
Emery urges Villa to use Europa triumph to fuel bold new era
-
US charges former Cuban president with murder as pressure builds
-
'Bohemian Rhapsody' star Malek says has Freddie Mercury 'in soul'
-
McGinn invites Prince William to join Villa's Europa celebrations
-
Zuckerberg says he feels 'weight' of Meta layoffs
-
Musk's SpaceX discloses filing for blockbuster IPO
-
Southampton lose appeal over Championship play-off removal
-
Cavs' Atkinson defends Harden, rues 'collective' defensive woes
-
Embattled Bolivia leader promises 'to listen' to protesters
-
US needs to 'put its footprint back on Greenland': Trump envoy
-
Tielemans reveals secret behind goal that inspired Villa's Europa glory
-
UN members reinforce nations' climate change obligations
-
Stylish Aston Villa win Europa League to end 30-year trophy drought
-
US needs to 'put its footprint back on Greenland': US envoy to AFP
-
Embattled Bolivia leader promises 'to listen' to protests
-
'Majority' of US Fed officials say rate hikes may be needed
-
Steelers quarterback Aaron Rodgers says 2026 his last NFL season
-
Kolkata see off Mumbai to keep IPL playoff hopes alive
-
Raul Castro: the other leader of Cuba's revolution
-
Spacey walks Cannes red carpet as comeback continues
-
US indicts former Cuban president as pressure builds
-
Ubisoft counts cost of restructuring with record annual loss
-
1996 Cuban downing of two US planes behind Raul Castro indictment
-
Silva says it's time for new Man City generation to shine
-
Airbnb expands into hotels, cars, groceries
-
Southampton appeal against Championship play-off removal for spying
-
Bolivia says protesters trying to 'disrupt democratic order'
-
Opposition backlash as Macron's choice gets nod for central bank
-
In-form Narvaez makes it three Giro stage wins
-
Mideast war drives up bond yields, budget risk
-
Ubisoft reports record annual loss after game delays, cancellations
-
Board of Peace report accuses Hamas of blocking Gaza progress
-
Boss of Germany's Commerzbank cheered as she slams UniCredit advances
-
Colosseum selfies, 'Melody' toffee and trade: Modi visits Rome
-
French presidential candidate Philippe targeted in embezzlement probe
-
UK eases sanctions on Russian jet fuel and diesel imports
-
Iran says US wants to 'start new war' after Trump threat
-
Magyar, Tusk tout Hungary's return to Europe in post-Orban era
-
Bangladesh measles deaths near 500 but vaccines offer hope
-
NATO chief says US troop withdrawals from Europe won't hurt defences
-
DR Congo Ebola risk high regionally, low worldwide: WHO
-
French lawmakers back Macron choice to run Bank of France
-
Borthwick to monitor Lawes as England great targets Test recall
Wellgistics Health to Announce First Quarter 2026 Financials on Tuesday May 19, 2026
TAMPA, FL / ACCESS Newswire / May 15, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced that it will report financial results for the first quarter of 2026 on Tuesday, May 19, 2026.
About Wellgistics Health, Inc.
Wellgistics Health (NASDAQ:WGRX) is a health information technology leader integrating its proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRx™ into its blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription drug dispensing journey. Its integrated platform connects more than 6,500 pharmacies and 200+ manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility verification, onboarding, adherence support, prior authorization, and cash-pay fulfillment designed to improve patient access and transparency across the prescription ecosystem.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable federal securities laws. Forward-looking statements include, without limitation, statements regarding the proposed acquisition of WellCare Today, LLC; the anticipated structure, valuation, consideration, preferred-stock terms and potential timing of any transaction; the Company's ability to complete due diligence, negotiate and enter into definitive agreements, obtain board approvals, secure financing, satisfy closing conditions and complete the proposed transaction; the potential integration of WellCare Today's platform, technology, personnel, programs and workflows with the Company's MSO, pharmacy network, provider and healthcare technology initiatives; the potential use of HealthAssist® and connected wearable technologies in RPM, RTM, CCM, medication adherence, patient engagement and care-coordination programs; the potential participation of pharmacies, providers, patients and payors; the potential availability of reimbursement for RPM, RTM, CCM or related services; the potential creation of revenue opportunities; and the Company's growth strategy, business plans and future performance.
Forward-looking statements may be identified by words such as "may," "could," "would," "should," "expect," "anticipate," "believe," "intend," "plan," "project," "estimate," "potential," "opportunity," "target," "forecast," "continue," "will" and similar expressions. These statements are based on current expectations, assumptions and estimates and are subject to risks and uncertainties, many of which are beyond the Company's control. Important factors that could cause actual results to differ materially include, but are not limited to: the risk that the parties do not enter into definitive agreements; the risk that the letter of intent is terminated or does not result in a completed transaction; the risk that the proposed valuation, consideration, preferred-stock terms or other transaction terms change materially; the risk that required financing, board approvals, third-party approvals or regulatory approvals are not obtained on acceptable terms or at all; the risk that Nasdaq shareholder approval or other Nasdaq requirements may apply depending on the final transaction terms; the risk that acquired technologies, programs or operations are not successfully integrated; the risk that anticipated benefits, synergies, provider adoption, pharmacy participation, patient engagement, reimbursement or revenue opportunities are not realized; risks associated with healthcare regulation, Medicare and payor requirements, fraud and abuse laws, privacy and data-security requirements, professional practice rules, device performance, third-party technology dependencies and changes in reimbursement policy; and other risks and uncertainties described in the Company's filings with the U.S. Securities and Exchange Commission.
Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law.
Wellgistics Media & Investor Contact
Media: [email protected]
Investor Relations: [email protected]
SOURCE: Wellgistics Health, Inc.
View the original press release on ACCESS Newswire
A.Ruiz--AT